Οι Αμερικανοί "ανακαλύπτουν" πάλι την Αμερική, κατά το κοινώς λεγόμενο! 87 χρόνια μετά την ανακάλυψη από τον Αμερικανό Ρ. Ρ. Ράϊφ της καταστροφής καρκινικών κυττάρων με την εφαρμογή βιοσυντονισμού, που άνοιξε τον δρόμο για την συγκεκριμμένη θεραπευτική μέθοδο και είχε σαν αποτέλεσμα, δυστυχώς, να εξοντωθεί ο ίδιος από τα πανίσχυρα (από τότε!) οικονομικά συμφέροντα στον χώρο της υγείας, Αμερικανοί και άλλοι ανά τον κόσμο ερευνητές έρχονται σήμερα να τον επιβεβαιώσουν! Στις σχετικές δημοσιεύσεις που είδαν το φως της δημοσιότητας αναφέρεται ότι δοκιμάστηκε η εφαρμογή ηλεκτρομαγνητικών πεδίων διαφόρων συχνοτήτων σε πάσχοντες από διάφορες μορφές καρκίνου με σημαντική αποτελεσματικότητα, γεγονός που δίνει μεγάλη ελπίδα για την θεραπευτική αντιμετώπιση του καρκίνου, χωρίς μάλιστα παρενέργειες, έτσι ώστε οι ασθενείς να αποφεύγουν στο μέλλον τις εξαιρετικά βλαπτικές σχετικές θεραπείες που εφαρμόζονται συνήθως.
Δείτε τις σχετικές δημοσιεύσεις παρακάτω:
Waking Times (Anna Hunt)
An important breakthrough may prevent people from suffering from
cancer or the aggressive radiation and chemotherapy treatments used to
kill cancer cells.
Anthony Holland, an Associate Professor and Director of Music
Technology at Skidmore College in New York, U.S., and his fellow
researchers discovered that, by creating custom digital electronic
signals, they can destroy cancer cells and Methicillin-resistant
Staphylococcus aureus (MSRA). In their laboratory experiments, the team
used Oscillating Pulsed Electric Fields (OPEF) to induce sympathetic
resonant vibrations which in a short amount of time shattered
targeted cells from pancreatic cancer, leukemia, ovarian cancer, and the
dangerous antibiotic-resistant bacterium MSRA. Below is an image showing the effect that the resonant frequencies had on leukemia cells.
Just as various sound frequencies can shatter different types of crystal and glass, shattering microscopic organisms is possible because they have many similar properties of liquid crystals.
Holland created a device that uses pulsating plasma lights to emit the right frequency electronic signals to induce sympathetic resonant vibration
in targeted microorganisms. Holland’s research showed that not only can
one change the vibration of a biological living microorganism with an
electronic signal, but also that different frequencies of this
electronic signal can be used to target different types of
microorganisms.
Below is a TED talk by Anthony Holland during which he reveals his discoveries. Starting midway through his talk, Holland shows stunning videos of how various cancer cells react to eleventh harmonic frequency combinations.
It took the researchers over 15 months of trying hundreds of frequency
combinations to find the ones with the potential to kill cancer cells.
Holland’s goal is to create a treatment that can be used to shatter
cancer cells and heal cancer patients painlessly and without toxic methods.
Br J Cancer. 2011 Aug 23;105(5):640-8. doi: 10.1038/bjc.2011.292. Epub 2011 Aug 9.
Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.
Costa FP1, de Oliveira AC, Meirelles R, Machado MC, Zanesco T, Surjan R, Chammas MC, de Souza Rocha M, Morgan D, Cantor A, Zimmerman J, Brezovich I, Kuster N, Barbault A, Pasche B.
Abstract
BACKGROUND:
Therapeutic
options for patients with advanced hepatocellular carcinoma (HCC) are
limited. There is emerging evidence that the growth of cancer cells may
be altered by very low levels of electromagnetic fields modulated at
specific frequencies.
METHODS:
A
single-group, open-label, phase I/II study was performed to assess the
safety and effectiveness of the intrabuccal administration of very low
levels of electromagnetic fields amplitude modulated at HCC-specific
frequencies in 41 patients with advanced HCC and limited therapeutic
options. Three-daily 60-min outpatient treatments were administered
until disease progression or death. Imaging studies were performed every
8 weeks. The primary efficacy end point was progression-free survival 6 months. Secondary efficacy end points were progression-free survival
and overall survival.
RESULTS:
Treatment
was well tolerated and there were no NCI grade 2, 3 or 4 toxicities. In
all, 14 patients (34.1%) had stable disease for more than 6 months.
Median progression-free survival was 4.4 months (95% CI 2.1-5.3) and
median overall survival was 6.7 months (95% CI 3.0-10.2). There were
three partial and one near complete responses.
CONCLUSION:
Treatment
with intrabuccally administered amplitude-modulated electromagnetic
fields is safe, well tolerated, and shows evidence of antitumour effects
in patients with advanced HCC.
Purpose
Because in vitro studies
suggest that low levels of electromagnetic fields may modify cancer
cell growth, we hypothesized that systemic delivery of a combination of
tumor-specific frequencies may have a therapeutic effect. We undertook
this study to identify tumor-specific frequencies and test the
feasibility of administering such frequencies to patients with advanced
cancer.
Patients and methods
We
examined patients with various types of cancer using a noninvasive
biofeedback method to identify tumor-specific frequencies. We offered
compassionate treatment to some patients with advanced cancer and
limited therapeutic options.
Results
We examined a total of 163 patients with a diagnosis of cancer and identified a total of 1524 frequencies ranging from 0.1 Hz to 114 kHz. Most frequencies (57–92%) were specific for a single tumor type. Compassionate treatment with tumor-specific frequencies was offered to 28 patients. Three patients experienced grade 1 fatigue during or immediately after treatment. There were no NCI grade 2, 3 or 4 toxicities. Thirteen patients were evaluable for response. One patient with hormone-refractory breast cancer metastatic to the adrenal gland and bones had a complete response lasting 11 months. One patient with hormone-refractory breast cancer metastatic to liver and bones had a partial response lasting 13.5 months. Four patients had stable disease lasting for +34.1 months (thyroid cancer metastatic to lung), 5.1 months (non-small cell lung cancer), 4.1 months (pancreatic cancer metastatic to liver) and 4.0 months (leiomyosarcoma metastatic to liver).Conclusion
Cancer-related
frequencies appear to be tumor-specific and treatment with
tumor-specific frequencies is feasible, well tolerated and may have
biological efficacy in patients with advanced cancer.
Chin J Cancer. 2013 Nov;32(11):573-81. doi: 10.5732/cjc.013.10177.
Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies.
Zimmerman JW1, Jimenez H, Pennison MJ, Brezovich I, Morgan D, Mudry A, Costa FP, Barbault A, Pasche B.
Abstract
In
the past century, there have been many attempts to treat cancer with
low levels of electric and magnetic fields. We have developed
noninvasive biofeedback examination devices and techniques and
discovered that patients with the same tumor type exhibit biofeedback
responses to the same, precise frequencies. Intrabuccal administration
of 27.12 MHz radiofrequency (RF) electromagnetic fields (EMF), which are
amplitude-modulated at tumor-specific frequencies, results in long-term
objective responses in patients with cancer and is not associated with
any significant adverse effects. Intrabuccal administration allows for
therapeutic delivery of very low and safe levels of EMF throughout the
body as exemplified by responses observed in the femur, liver, adrenal
glands, and lungs. In vitro studies have demonstrated that
tumor-specific frequencies identified in patients with various forms of
cancer are capable of blocking the growth of tumor cells in a tissue-
and tumor-specific fashion. Current experimental evidence suggests that
tumor-specific modulation frequencies regulate the expression of genes
involved in migration and invasion and disrupt the mitotic spindle. This
novel targeted treatment approach is emerging as an appealing
therapeutic option for patients with advanced cancer given its excellent
tolerability. Dissection of the molecular mechanisms accounting for the
anti-cancer effects of tumor-specific modulation frequencies is likely
to lead to the discovery of novel pathways in cancer.
http://www.ncbi.nlm.nih.gov/pubmed/24206915
http://www.ncbi.nlm.nih.gov/pubmed/24206915
Br J Cancer. 2012 Jan 17;106(2):307-13. doi: 10.1038/bjc.2011.523. Epub 2011 Dec 1.
Cancer cell proliferation is inhibited by specific modulation frequencies.
Zimmerman JW1, Pennison MJ, Brezovich I, Yi N, Yang CT, Ramaker R, Absher D, Myers RM, Kuster N, Costa FP, Barbault A, Pasche B.
Abstract
BACKGROUND:
There
is clinical evidence that very low and safe levels of
amplitude-modulated electromagnetic fields administered via an
intrabuccal spoon-shaped probe may elicit therapeutic responses in
patients with cancer. However, there is no known mechanism explaining
the anti-proliferative effect of very low intensity electromagnetic
fields.
METHODS:
To
understand the mechanism of this novel approach, hepatocellular
carcinoma (HCC) cells were exposed to 27.12 MHz radiofrequency
electromagnetic fields using in vitro exposure systems designed to
replicate in vivo conditions. Cancer cells were exposed to
tumour-specific modulation frequencies, previously identified by
biofeedback methods in patients with a diagnosis of cancer. Control
modulation frequencies consisted of randomly chosen modulation
frequencies within the same 100 Hz-21 kHz range as cancer-specific
frequencies.
RESULTS:
The
growth of HCC and breast cancer cells was significantly decreased by
HCC-specific and breast cancer-specific modulation frequencies,
respectively. However, the same frequencies did not affect proliferation
of nonmalignant hepatocytes or breast epithelial cells. Inhibition of
HCC cell proliferation was associated with downregulation of XCL2 and
PLP2. Furthermore, HCC-specific modulation frequencies disrupted the
mitotic spindle.
CONCLUSION:
These
findings uncover a novel mechanism controlling the growth of cancer
cells at specific modulation frequencies without affecting normal
tissues, which may have broad implications in oncology.
Δείτε παρακάτω και τα σχετικά βίντεο:
Για οποιαδήποτε πρόσθετη πληροφορία και οποιαδήποτε απορία
Καλέστε στο +30.6932 256 284 ή
Στείλτε e-mail στο viosyn.gr@gmail.com
Καλέστε στο +30.6932 256 284 ή
Στείλτε e-mail στο viosyn.gr@gmail.com
.png "English"){kind=small}
0 σχόλια:
Δημοσίευση σχολίου